named programs · 2 · from sources
What they call their work
Alumni Insights Series
Curated publication series featuring standout End of Program Projects from graduates, highlighting cutting-edge topics in medical research ethics, AI in healthcare, and global health policy.
Certification in Medicines Development (CMD) Program
Advanced professional certification program in partnership with King’s College London, designed for medical professionals in pharmaceutical medicine, focusing on ethical, regulatory, and scientific aspects of drug development.
activities · 3 groups
What they do
-
Medical Professional Education & Training 2 activities
- Continuing professional development in pharmaceutical medicineOrganizes and supervises continuing professional development education programs for biomedical and healthcare professionals, focusing on pharmaceutical medicine and medicines development across the product lifecycle.
- Delivery of modular education programs in medicines developmentProvides standalone and integrated modular training in medicines development, including Module 1 (clinical pharmacology, regulations, clinical development), Module 2 (medical affairs, health economics, commercialization, digital technologies), and Module 3 (drug discovery, non-clinical safety, human trials), offered as part of or alongside the full Certification in Medicines Development program.
-
-
Medical Research & Education Dissemination 1 activity
- Conduct and publication of applied research projectsConducts and publishes applied research through End of Program Projects by participants in the Certification in Medicines Development program, including analysis of the 2024 revision of the Declaration of Helsinki and ethical regulation of direct-to-consumer advertising of prescription drugs, with selected works published in the GMDP Academy Alumni Insights series.
-
-
Uncategorized 1 activity
- Certification in Medicines Development programOffers a ten-month Certification in Medicines Development (CMD) program covering all stages of the drug lifecycle, available as a full certification or through individual modules, in partnership with King’s College London. Since 2017, 798 professionals from over 50 countries have completed the program, with 59 professionals from 30 countries enrolled in the Class of 2026.
-
financials · form 990 · fy2024
revenue
Total revenue$649K
Contributions & grants$00%
Program service revenue$649K100%
Investment income$00%
Other revenue$0
expenses
Total expenses$798K
Program expenses91%
Admin / overhead9%
Fundraising0%
Salaries & benefits$237K
Grants paid out$0
Largest expense lineCompensation
balance sheet
Total assets$360K
Cash$360K
Investments$0
Liabilities$500
Net assets$360K
Liquid reserves5.4 mo
5 years on record · 2020–2024 · YoY revenue -3.5%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 3
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| PRAVIN CHOPRA | CEO | 40 | $68K |
| HONORIO SILVA | PROGRAM DIRECTOR | 40 | $45K |
| SONEIL GUPTHA | DIRECTOR | 2 | $1K |
board members · 6
- DOMENICO CRISUOLO — DIRECTOR
- EDDIE POWER — DIRECTOR
- PETER STONIER — DIRECTOR
- SAM SALEK — DIRECTOR
- SANDOR KERPEL-FRONIUS — DIRECTOR
- XAVIER LURIA — DIRECTOR
relationships · 13
Who they work with
- King's College London Partner — Collaborates with GMDP Academy to deliver the Certification in Medicines Development (CMD) program.
- King’s College London Partner — Academic partner in delivering Module 1 of the Certification in Medicines Development program.
- King’s College London Partner — Academic partner in delivering the ten-month Certification in Medicines Development program.
- King’s College London Partner — Academic partner in the Certification in Medicines Development (CMD) program.
- King’s College London Partner — Academic partner in the GMDP Academy Certification in Medicines Development program.
- King’s College London Partner — Collaborates on a professional certification program in medicines development.
- King’s College London Partner — Collaborates with King’s College London to develop the Certification in Medicines Development program.
- King’s College London Partner — Developed the Certification in Medicines Development in partnership with GMDP Academy Inc.
- King’s College London Partner — Offers the Certification in Medicines Development program in partnership with GMDP Academy.
- King’s College London Partner — Partnership for the Certification in Medicines Development program
- King’s College London Partner — Partnership to deliver the full ten-month CMD certification program.
- Opella Healthcare Partner — Dr. Epaïnète Gawa serves as Global Medical Lead at Opella Healthcare, where he shapes evidence-based strategies and leads global medical initiatives.
- Sanofi Partner — Dr. Epaïnète Gawa previously worked at Sanofi, gaining pharmaceutical industry experience before joining Opella Healthcare Group.
strategies · 4
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Integrated, Evidence-Based Curriculum for Medicines Development 79 orgsmethodology: integrated-curriculumBy integrating scientific, clinical, statistical, and regulatory knowledge into a cohesive and evidence-based framework, the organization builds professional competency across the drug development lifecycle, because a systems-level understanding improves decision-making and ultimately patient outcomes.shared approach: Integrated Research-Clinical Model →
- Professional Education Aligned with Strategic and Business Realities 79 orgsmethodology: strategic-alignment-through-SWOT-and-timelinesBy combining scientific leadership with business acumen and strategic planning tools, the organization prepares professionals to navigate complex pharmaceutical environments, because effective medicines development requires alignment with market needs, regulatory strategy, and healthcare delivery systems.shared approach: Integrated Research-Clinical Model →
- Adaptive, Lifelong Professional Development Model 21 orgsmethodology: adaptive-professional-educationBy offering flexible, modular, and continuously updated education programs, the organization supports professionals throughout their careers, because medicines development is an evolving field requiring ongoing learning and adaptation to maintain scientific rigor and regulatory relevance.shared approach: Evidence-Based Education →
- Global Peer Network as Educational Foundationmethodology: global community-based learningBy embedding a global community of practice within its educational model, the organization enhances learning and retention, because peer-based discussion and shared experience foster deeper understanding and professional accountability in medicines development.